Clinical experience with triptans

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Many drugs are now available for treating migraine attacks, including agents specifically indicated for this condition. Since 1990 sumatriptan, the first 5-HT1B,1D receptor agonist, was introduced and realized a real breakthrough in therapy; other agents of this class of drugs called triptans have more recently been used. All of them are effective in relieving the symptoms of migraine, but each exhibits pharmacological and/or clinical features that must be considered for the optimal care and management of the patient. We present here a short overview on the main clinical features of the triptans already in use in Italy.

Cite

CITATION STYLE

APA

Zanchin, G., Dainese, F., Mainardi, F., & Maggioni, F. (2001). Clinical experience with triptans. Journal of Headache and Pain, 2(SUPPL. 1). https://doi.org/10.1007/s101940170021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free